A Look at the Clinical Benefits of the FDA’s Expanded Access Program

Leggi l'articolo originale


A single-center evaluation of the FDA’s Expanded Access program indicated broad use of the program among the center’s patients, including a large percentage of pediatric patients.

Lascia un commento